| pubmed-article:7770717 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C0024623 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C2243049 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C0008783 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C0015620 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C0019593 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C0034665 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:7770717 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:7770717 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:7770717 | pubmed:dateCreated | 1995-7-6 | lld:pubmed |
| pubmed-article:7770717 | pubmed:abstractText | Histamine-2 receptor antagonist (H2-RA) have been shown to improve the function of various parts of the immune system. The proposed mechanism of the immunomodulative effects of H2-RA has been considered to be the inhibition of suppressor T-lymphocyte activity, an increase in interleukin-2 production, and an enhancement of natural killer cell activity. Most of these studies were done with cimetidine. Comparative data with other H2-RA are limited and conflict on immunomodulative effects. Comparison of the actions of H2-RA on the immune system is required. | lld:pubmed |
| pubmed-article:7770717 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7770717 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7770717 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7770717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7770717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7770717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7770717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7770717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7770717 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7770717 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:7770717 | pubmed:issn | 0036-5521 | lld:pubmed |
| pubmed-article:7770717 | pubmed:author | pubmed-author:KaneJ MJM | lld:pubmed |
| pubmed-article:7770717 | pubmed:author | pubmed-author:KimW HWH | lld:pubmed |
| pubmed-article:7770717 | pubmed:author | pubmed-author:LeeS ISI | lld:pubmed |
| pubmed-article:7770717 | pubmed:author | pubmed-author:ParkI SIS | lld:pubmed |
| pubmed-article:7770717 | pubmed:author | pubmed-author:HahmK BKB | lld:pubmed |
| pubmed-article:7770717 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7770717 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:7770717 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7770717 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7770717 | pubmed:pagination | 265-71 | lld:pubmed |
| pubmed-article:7770717 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:meshHeading | pubmed-meshheading:7770717-... | lld:pubmed |
| pubmed-article:7770717 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7770717 | pubmed:articleTitle | Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients. | lld:pubmed |
| pubmed-article:7770717 | pubmed:affiliation | Dept. of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. | lld:pubmed |
| pubmed-article:7770717 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7770717 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7770717 | pubmed:publicationType | In Vitro | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7770717 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7770717 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7770717 | lld:pubmed |
